Savient Pharmaceuticals (SVNT) Misses All Q1 Expectations

May 9, 2012 7:37 AM EDT
Get Alerts SVNT Hot Sheet
Trade SVNT Now!
Join SI Premium – FREE
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q1 EPS of ($0.49), $0.03 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $4.59 million.

For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment